Very-high-risk localized prostate cancer: definition and outcomesDebasish Sundi, Ashley E. Ross, Vinson Wang et al.|Prostate Cancer and Prostatic Diseases|2013Cited by 110
Prostate Specific Membrane Antigen Targeted <sup>18</sup> F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center StudyMichael A. Gorin, Mohamad E. Allaf, Steven P. Rowe et al.|The Journal of Urology|2017Cited by 95
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M. Hahn, Daniel M. Geynisman, Trinity J. Bivalacqua et al.|Clinical Cancer Research|2016Cited by 72
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experiencePhillip M. Pierorazio, Trinity J. Bivalacqua, Michael A. Gorin et al.|The Prostate|2013Cited by 60
Attenuated RhoA/Rho-kinase Signaling in Penis of Transgenic Sickle Cell MiceTrinity J. Bivalacqua, Arthur L. Burnett, Ashley E. Ross et al.|Urology|2010Cited by 48